Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways
Authors:
- Takashi IwaiTITakashi Iwai
- Yohei HayashiYHYohei Hayashi
- Saori NaritaSNSaori Narita
- Yuko KasuyaYKYuko Kasuya
- Kazushi JinKJKazushi Jin
- Mamiko TsuganeMTMamiko Tsugane
- Jun-Ichiro OkaJOJun-Ichiro Oka
- 1 December 2009
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 204 (1) , 235-240
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in miceNeuroscience & Biobehavioral Reviews, 2005
- Genetic and Pharmacological Evidence of a Role for GABAB Receptors in the Modulation of Anxiety- and Antidepressant-Like BehaviorNeuropsychopharmacology, 2004
- In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified miceMolecular Psychiatry, 2004
- Intra- and interstrain differences in models of “behavioral despair”Pharmacology Biochemistry and Behavior, 2001
- Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor SignalingJournal of Biological Chemistry, 2001
- Dopamine receptors: Molecular biology, biochemistry and behavioural aspectsPharmacology & Therapeutics, 1994
- Effects of diazepam, pentobarbital, scopolamine and the timing of saline injection on learned immobility in ratsPhysiology & Behavior, 1991
- Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?Fundamental & Clinical Pharmacology, 1990
- Dopamine and depression: A review of recent evidence. II. Theoretical approachesBrain Research Reviews, 1983
- Involvement of α- and β1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming testNeuropharmacology, 1983